Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

The Dural Graft Market to show an inclination towards digitized innovation

 

 

The Dural Graft Market is expected to grow at an unstoppable rate In Upcoming Years. With environmental health being a matter of concern, everything – right from public transport networks, power supply, and storage of waste to monitoring the ecological balance is being taken up by IoT and AI. It could, thus, be inferred that with “smart cities” would come “smart end-user solutions” in the years to come.

The Dural Graft Market Share is estimated to be reaching US$ 1.1 Billion at a CAGR of 6% from 2019 to 2029. With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward.

Global demand for dural graft is expected to grow significantly, owing to rising burden of neurosurgical diseases leading to increasing cranial and spinal duraplasty, and rapid technological advancements in dural graft products.

Moreover, increasing global neurosurgical workforce, extensive clinical research, and increasing demand for CNS dural repair are responsible for increasing the adoption of dural graft products.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/25285

Company Profiles

  • Cook Medical.
  • Integra Lifesciences Corporation
  • B Braun
  • Cousin Biotech,
  • Natus Medical Incorporated
  • Tissuemed Ltd,
  • Vostra GmbH
  • Stryker Corporation
  • Medtronic Plc.
  • Johnson & Johnson,
  • Aesculap, Inc.
  • Baxter International Inc

For instance, in 2004, the World Health Organization (WHO) estimated that, there were 33,193 neurosurgeons worldwide, including trainees. Whereas, in 2015, this number rose to approximately 49,940 neurosurgeons, with a 4% total growth, worldwide.

Persistence Market Research predicts that, the global dural graft market will exhibit a 6% CAGR<span style=”font-weight: 400;”> during the forecast period (2019-2029).

Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com

Key Takeaways of Dural Graft Market Study

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/25285

“Increasing scientific evidence from industry-led clinical trials and technological advancements in dural graft products are expected to support the significant adoption of synthetic nanofibrous dural grafts.” says a PMR analyst.

Brain and Spinal Tumor Application Dominating Dural Graft Market

Prevalence of CNS tumors due to neurological conditions is growing rapidly. Chiari malformation and spinal cord tumor-related neurosurgical procedures requiring dural grafts for surgeries are becoming more frequent. Growing risk of such neurological conditions demands neurosurgical procedures along with duraplasty for effective and safe treatment outcomes.

For instance, in 2018, more than 50% of dural grafts were used in cranial and spine tumor operations. This high proportion is estimated to continue in the future.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/25285

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the dural graft market in its latest study, presenting historical demand assessment from 2014-2018 and projections for 2019-2029, on the basis of product type (xenogeneic dural graft, synthetic dural graft, autologous dural graft, and allogeneic dural graft), application (brain and spine tumor, traumatic brain and spine injury, cerebrospinal fluid (CSF) accumulation, cerebrovascular accident, epilepsy, and others), material (bovine pericardium, autologous pericardium, synthetic polymers, ligamentum nuchae, and others), and end user (hospitals, ambulatory surgical centers, trauma centers, and clinics), across seven key regions.

About us: Persistence Market Research

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts